Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 41 - 50 of 243
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Chongqing Medical Equipment Factory Co., Ltd.
Project Stage: Marketed
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Other
Project Stage: Lead Optimization
Alternative Name: Inhibition of Vas Propulsive Contractility
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: King's College, London
Project Stage: Lead Optimization
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Transdermal
Developer: Viramal Limited
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: No
Delivery Type: Vaginal Gel, Vaginal, Other
Developer: Central Drug Research Institute, India, HLL Lifecare Limited
Project Stage: Regulatory
Alternative Name: BioRings Intravaginal Ring
Active Status: Yes
User: Female
Mode: No
Delivery Type: Vaginal Ring
Developer: BioRings, Weill Cornell Medical College, QPharma
Project Stage: Pre-clinical
Alternative Name: Carboxy Terminus Peptide of β-human chorionic gonadotropin
Active Status: Unknown
User: Female
Mode: No
Developer: WHO, Talwar Research Foundation
Project Stage: Phase II
Alternative Name: Nanocomposite Copper (Cu) IUD
Active Status: Yes
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Tongji Medical College at Huazhong University of Science and Technology
Project Stage: Marketed
Alternative Name: l'Amour®; Jeitosa®
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier
Developer: Cupid Ltd.
Project Stage: SRA/WHO PQ Approved
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier
Developer: Cupid Ltd.

Pages

CSV